Qiang Li - Concepedia

Author

Qiang Li

Tianjin Medical University Cancer Institute and Hospital ORCID

Also Known As

L I Qiang, Li Qiang, Qiang Li, Qiang Li (8118), Qiang li

117

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Tianjin Medical University Cancer Institute and Hospital Dana-Farber Cancer Institute Harvard University Tianjin Medical University Second Military Medical University

About

Qiang Li is an author at Tianjin Medical University Cancer Institute and Hospital specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	927
2	Cell Biology	4	4	292
3	Engineering	1	1	10
4	Health Sciences	1	1	10
5	Biomedical Engineering	1	1	10

Qiang Li

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial Dongsheng Yue, Shidong Xu, Qun Wang, The Lancet Respiratory Medicine MedicinePathologyErlotinib Versus VinorelbineCancer TreatmentCancer Genetics	2018	288
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer Julien Dilly, Megan T. Hoffman, Laleh Abbassi, Cancer Discovery Kras InhibitorsPancreatic CancerOncogenic AgentMedicineReceptor Tyrosine Kinase	2024	182
A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma Dong Hui, Qiang Li, Jian Wang, Digestive and Liver Disease Surgical OncologyCancer ImmunosurveillanceHepatologyRadical ResectionMedicine	2008	150
Correlations of Tumor-associated Macrophage Subtypes with Liver Metastases of Colorectal Cancer Yunlong Cui, Huikai Li, Hong-Yuan Zhou, Asian Pacific Journal of Cancer Prevention	2013	91
Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma Xiaohong Shen, Na Li, Hui Li, Journal of Cancer Research and Clinical Oncology Cancer ImmunosurveillanceHepatologyHepatocellular CarcinomaLiver PhysiologyT-regulatory Cell	2010	90
TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration Yuchuan Jiang, Siliang Chen, Qiang Li, Frontiers in Immunology	2021	74
Combined Treatment of Pancreatic Cancer with Mithramycin A and Tolfenamic Acid Promotes Sp1 Degradation and Synergistic Antitumor Activity Zhiliang Jia, Yong Gao, Liwei Wang, Cancer Research Tumor BiologyOncologyPancreatic CancerMedicineTumor Growth	2010	71
cIAP1/2 antagonism eliminates MHC class I–negative tumors through T cell–dependent reprogramming of mononuclear phagocytes Kevin Roehle, Qiang Li, Katherine S. Ventre, Science Translational Medicine	2021	64
A comprehensive evaluation of clinical efficacy and safety of celecoxib in combination with chemotherapy in metastatic or postoperative recurrent gastric cancer patients Qinghong Guo, Qiang Li, Jiong Wang, Medicine	2019	52
Clinicopathological significance of E-cadherin, VEGF, and MMPs in gastric cancer Yongning Zhou, Gaozhong Li, Jing Wu, Tumor Biology	2010	51

Page 1